Through a series of brief presentations on three key topic areas, this webinar will help early-phase cell therapy developers identify insights to mitigate risk and ensure clinical readiness to position their programs for success. Specific topic areas of focus include:

•    Navigating an evolving cell therapy regulatory landscape
•    How to assess GMP-readiness and prepare your cell therapy workflow for clinical and commercial manufacturing
•    Ensuring patient-centricity in the complex cell therapy ecosystem and leveraging a unique, comprehensive operating model for your product

The speakers include: 

Michele Duggan Sr. Manager, Regulatory Affairs

Mindy Sadik, Ph.D. Director, Cell Therapy Sciences

Kim Watanabe, Ph.D. Executive Director, Cell and Gene Therapy Pillar Head